Tischkowitz, M., Brunet, J., Bégin, L. R., Huntsman, D. G., Cheang, M. C., Akslen, L. A., . . . Foulkes, W. D. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BioMed Central.
Citação norma ChicagoTischkowitz, Marc, Jean-Sébastien Brunet, Louis R. Bégin, David G. Huntsman, Maggie CU Cheang, Lars A. Akslen, Torsten O. Nielsen, and William D. Foulkes. Use of Immunohistochemical Markers Can Refine Prognosis in Triple Negative Breast Cancer. BioMed Central, 2007.
MLA citiranjeTischkowitz, Marc, et al. Use of Immunohistochemical Markers Can Refine Prognosis in Triple Negative Breast Cancer. BioMed Central, 2007.
Opozorilo: Ti citati niso vedno 100% točni.